This is an outdated version published on 2020-12-31. Read the most recent version.
Scientific Letters
Vol. 13 No. 1 (2021): Mediterranean Journal of Hematology and Infectious Diseases, Volume 13, 2021
https://doi.org/10.4084/mjhid.2021.008

Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience

Coronavirus in patients with thalassemias

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: September 11, 2020
Accepted: December 12, 2020
Published: December 31, 2020

Versions

1421
Views
428
Downloads
150
HTML

Authors

Mehran Karimi
mkarimi820@gmail.com
a:1:{s:5:"en_US";s:65:"Hematology Research Center, Shiraz University of Medical Sciences";}, Iran, Islamic Republic of.
Sezaneh Haghpanah
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz , Iran, Islamic Republic of.
Azita Azarkeivan
Zafar Adult Thalassemia Clinic, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran, Islamic Republic of.
Sara Matin
Pediatric Department, Jahrom University of Medical Sciences, Jahrom, Iran, Islamic Republic of.
Arash Safaei
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz , Iran, Islamic Republic of.
Vincenzo De Sanctis
Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy.

None

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
European Centre for Disease Prevention and Control. COVID-19 situation update
worldwide, as of 7 September 2020. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.
Peng F, Tu L, Yang Y, Hu P, Wang R, Hu Q, Cao F, Jiang T, Sun J, Xu G, Chang C. Managementand treatment of COVID-19: the Chinese experience. Can J Cardiol. 2020; 36:915-930. .
de Sanctis V, Canatan D, Corrons JLV, Karimi M, Daar S, Kattamis C, Soliman AT, Wali Y, Alkindi S, Huseynov V, Nasibova A, Tiryaki TO, Evim MS, Gunes AM, Karakas Z, Christou S, Campisi S, Zarei T, Khater D, Oymak Y, Kaleva V, Stoyanova D, Banchev A, Galati MC, Yassin MA, Kakar S, Skafida M, Kilinc Y, Alyaarubi S, Verdiyevas N, Stoeva I, Raiola G, Mariannis D, Ruggiero L, Di Maio S. Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study. Mediterr J Hematol Infect Dis. 2020;12(1): e2020046. Published 2020 Jul 1. doi:10.4084/MJHID.2020.046.
Karimi M, De Sanctis V. Implications of SARSr-CoV 2 infection in thalassemias: do patients fall into the "high clinical risk" category? Acta Biomed. 2020; 91:50–56.
He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP. COVID-19 in persons with haematological cancers. Leukemia. 2020; 34:1637-1645.
Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020; NEJMoa2020283. doi:10.1056 /NEJMoa2020283.
Modell B. Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Organ.2008;86:480–487.
Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A.Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014;31:583-596.
World Health Organisation; 2020. National Health Commission of the People's Republic of China. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7) Available at: http://www.nhc.gov.cn/xcs/zhengcwj/ 202002 / 3b09b894ac9b4204a79db5b8912d4440.shtml2020. Accessed February 5, 2020.
CDC (Centers for Disease Control and Prevention): https://www.cdc.gov/coronavirus/ 2019-ncov/covid-data/investigations-discovery/assessing-risk-factor
Karimi M, Haghpanah S, Azarkeivan A, Zahedi Z, Zarei T, Akhavan Tavakoli M, Bazrafshan A, Shirkavand A, De Sanctis V. Prevalence and mortality in b-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience. Br J Haematol. 2020;190:e137-e140.
Hooman Tadbiri, Maziar Moradi-Lakeh, Mohsen Naghavi. Letter to the editor: COVID-19 and all-cause excess mortality in Iran in spring 2020. Med J Islam Repub Iran. 2020 (22 Sep);34.125. https://doi.org/10.34171/mjiri.34.125.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6): e20200702. doi:10.1542/peds.2020-0702.
Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol.2020;16:341-342.

How to Cite



“Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience: Coronavirus in patients with thalassemias” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021008. doi:10.4084/mjhid.2021.008.
Copyright (c) 2020 Mehran Karimi, Sezaneh Haghpanah , Azita Azarkeivan , Sara Matin, Arash Safaei, Vincenzo De Sanctis Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.